Results for tag: "Turner Syndrome Drug"

The Turner Syndrome Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. It is composed of drugs used to treat the chromosomal disorder Turner Syndrome, which is caused by the complete or partial absence of the second sex chromosome. Common symptoms of the disorder include short stature, ovarian failure, and infertility. Treatment options for Turner Syndrome include hormone replacement therapy, growth hormone therapy, and fertility treatments. The Turner Syndrome Drug market is composed of a variety of pharmaceutical companies, including Pfizer, Novo Nordisk, and Merck. Other companies in the market include Sanofi, Eli Lilly, and Bayer. These companies are focused on developing treatments for Turner Syndrome, such as hormone replacement therapies, growth hormone therapies, and fertility treatments. Show Less Read more